Learn more

CONSEJO SUPERIOR INVESTIGACION

Overview
  • Total Patents
    5,414
  • GoodIP Patent Rank
    1,766
  • Filing trend
    ⇧ 40.0%
About

CONSEJO SUPERIOR INVESTIGACION has a total of 5,414 patent applications. It increased the IP activity by 40.0%. Its first patent ever was published in 1959. It filed its patents most often in Spain, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CENTRE NAT RECH SCIENT, UNIV OKAYAMA NAT UNIV CORP and CONSIGLIO NAZIONALE RICERCHE.

Patent filings per year

Chart showing CONSEJO SUPERIOR INVESTIGACIONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Corma Canos Avelino 280
#2 Rey Garcia Fernando 76
#3 Garces Rafael 60
#4 Canos Avelino Corma 48
#5 Valencia Valencia Susana 45
#6 Corma Canós Avelino 45
#7 Akinfiev Teodor 41
#8 Marcos Celestino Susana 41
#9 Domine Marcelo Eduardo 40
#10 Torrecillas San Millan Ramon 39

Latest patents

Publication Filing date Title
ES2811650A1 SYSTEM AND METHOD OF GENERATION OF CONFOCAL ACOUSTIC BEAMS OF VORTEX WITH SPACE-TEMPORARY OVERLAY (Machine-translation by Google Translate, not legally binding)
US2020268248A1 Method of estimating a full shape of the crystalline lens from measurements taken by optic imaging techniques and method of estimating an intraocular lens position in a cataract surgery
WO2020141244A1 Resistive heat source for thin film deposition by means of vacuum evaporation
WO2020136221A1 Use of secoiridoids for the treatment of optic neuritis
WO2020136301A1 Holdemanella sp. bacterium and use thereof
WO2020127332A1 Method for the introduction of genetic information in cell by site-specific integration system
WO2020128125A1 Method for isolating the unsaponifiable fraction of oils or fats by supported liquid extraction
WO2020109646A1 Phascolarctobacterium faecium for use in the prevention and treatment of obesity and its comorbidities
WO2020109414A1 Christensenellaceae bacteria including christensenella minuta and uses thereof
WO2020094764A1 Double and inducible suicide gene construct and its use in gene therapy
WO2020099119A1 Etanercept variants with improved therapeutical effect
ES2822223A1 Combined optical telescope with scalable aperture
WO2020099696A1 Use of esters derived from gallic acid as antivirals
WO2020099695A1 Method for obtaining a solid material with gaseous aggregates by means of magnetron cathode sputtering in static or quasistatic conditions to reduce the use of gas
WO2020079302A2 Nanostructured lipid gel, method for preparation and use
ES2818774A1 Monolith formed of porous carbon obtained from whey, procedure of obtaining and uses
ES2818298A1 Procedure for the preparation of hydrophobic aerogels
CA3114555A1 Acylhydrazones for the treatment of neurological diseases
EP3798606A1 Optofluidic device for monitoring the evolution of liquid products by near-infrared spectroscopy
ES2814048A1 COMBINED USE OF BIOTIN AND THYAMINE IN THE TREATMENT OF HUNTINGTON DISEASE (Machine-translation by Google Translate, not legally binding)